ZA202205093B - Biochemical reaction methods and reagents comprising intrinsically disordered regions - Google Patents

Biochemical reaction methods and reagents comprising intrinsically disordered regions

Info

Publication number
ZA202205093B
ZA202205093B ZA2022/05093A ZA202205093A ZA202205093B ZA 202205093 B ZA202205093 B ZA 202205093B ZA 2022/05093 A ZA2022/05093 A ZA 2022/05093A ZA 202205093 A ZA202205093 A ZA 202205093A ZA 202205093 B ZA202205093 B ZA 202205093B
Authority
ZA
South Africa
Prior art keywords
macromolecules
polypeptides
biochemical reaction
relates
idrs
Prior art date
Application number
ZA2022/05093A
Other languages
English (en)
Inventor
Niall Armes
Hannah Williams
Matthew Forrest
Mathew Parker
Sidong Liu
Lauren Parker
Original Assignee
Biocrucible Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocrucible Ltd filed Critical Biocrucible Ltd
Publication of ZA202205093B publication Critical patent/ZA202205093B/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6848—Nucleic acid amplification reactions characterised by the means for preventing contamination or increasing the specificity or sensitivity of an amplification reaction
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6844—Nucleic acid amplification reactions
    • C12Q1/6853—Nucleic acid amplification reactions using modified primers or templates
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2521/00—Reaction characterised by the enzymatic activity
    • C12Q2521/50—Other enzymatic activities
    • C12Q2521/507—Recombinase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2522/00—Reaction characterised by the use of non-enzymatic proteins
    • C12Q2522/10—Nucleic acid binding proteins
    • C12Q2522/101—Single or double stranded nucleic acid binding proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2527/00—Reactions demanding special reaction conditions
    • C12Q2527/125—Specific component of sample, medium or buffer

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Immunology (AREA)
  • Analytical Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Apparatus Associated With Microorganisms And Enzymes (AREA)
  • Immobilizing And Processing Of Enzymes And Microorganisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
ZA2022/05093A 2019-11-11 2022-05-09 Biochemical reaction methods and reagents comprising intrinsically disordered regions ZA202205093B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB1916379.9A GB201916379D0 (en) 2019-11-11 2019-11-11 Biochemical reaction methods and reagents
PCT/GB2020/052866 WO2021094746A1 (en) 2019-11-11 2020-11-11 Biochemical reaction methods and reagents comprising intrinsically disordered regions

Publications (1)

Publication Number Publication Date
ZA202205093B true ZA202205093B (en) 2024-10-30

Family

ID=69062276

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2022/05093A ZA202205093B (en) 2019-11-11 2022-05-09 Biochemical reaction methods and reagents comprising intrinsically disordered regions

Country Status (13)

Country Link
US (2) US12618102B2 (enExample)
EP (1) EP4058599A1 (enExample)
JP (2) JP7840266B2 (enExample)
KR (1) KR20220113948A (enExample)
CN (1) CN114945682A (enExample)
AU (1) AU2020382121B2 (enExample)
BR (1) BR112022009072A2 (enExample)
CA (1) CA3157435A1 (enExample)
GB (1) GB201916379D0 (enExample)
IL (1) IL292885A (enExample)
MX (1) MX2022005677A (enExample)
WO (1) WO2021094746A1 (enExample)
ZA (1) ZA202205093B (enExample)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN108998406B (zh) * 2018-08-03 2022-05-10 福州大学 一种人类原代培养细胞基因组编辑、定点基因敲入方法
GB201916379D0 (en) 2019-11-11 2019-12-25 Biocrucible Ltd Biochemical reaction methods and reagents
CN113355389B (zh) * 2020-03-05 2022-11-15 广西扬翔股份有限公司 利用CRISPR/Cas12a系统靶向富集核酸目标区域的方法及其应用
EP3992635A1 (en) 2020-10-29 2022-05-04 midge medical GmbH System and a device for detecting a target analyte
US20240110221A1 (en) * 2022-09-30 2024-04-04 Illumina, Inc. Methods of modulating clustering kinetics
CN116251621B (zh) * 2022-12-13 2024-08-23 中国科学院基础医学与肿瘤研究所(筹) 一种提高氯化血红素的过氧化物酶活性的方法
WO2024178628A1 (en) * 2023-02-28 2024-09-06 Sun Yat-Sen University Epigenetic editor assisted by phase separation proteins
US12612667B1 (en) * 2023-05-01 2026-04-28 National Technology & Engineering Solutions Of Sandia, Llc Solid phase recombinase polymerase amplification for human pathogen identification
JP2024179837A (ja) * 2023-06-16 2024-12-26 国立大学法人 東京大学 酵素の検出方法及び酵素の検出キット
KR20250022285A (ko) 2023-08-07 2025-02-17 포항공과대학교 산학협력단 액체-액체 상분리를 통한 scotin 프롤린-풍부 도메인 생체분자 응축물 및 그의 응용
WO2025137528A1 (en) * 2023-12-20 2025-06-26 Abbott Laboratories Reducing agent compositions for isothermal amplification of nucleic acids
GB2643378A (en) * 2024-07-15 2026-02-18 Biocrucible Ltd Reagents and methods
WO2026131829A1 (en) 2024-12-16 2026-06-25 Neoenta LLC Devices for analysis of a biological sample and manufacturing methods thereof, and methods of anaylsis of a biological sample
GB202500508D0 (en) 2025-01-15 2025-02-26 Biocrucible Ltd Molecular diagnostic device

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7399590B2 (en) * 2002-02-21 2008-07-15 Asm Scientific, Inc. Recombinase polymerase amplification
DK1499738T3 (da) 2002-02-21 2008-11-17 Asm Scient Inc Recombinase-polymerease-amplifikation
CA2560758A1 (en) 2004-04-21 2005-11-03 Toray Industries, Inc. Lab-on-chip substrate
DE102005052752A1 (de) 2005-11-04 2007-05-10 Clondiag Chip Technologies Gmbh Vorrichtung und Verfahren zum Nachweis von molekularen Wechselwirkungen
EP2829615B1 (en) 2005-07-25 2018-05-09 Alere San Diego, Inc. Kit for multiplexing recombinase polymerase amplification
US20070059713A1 (en) 2005-09-09 2007-03-15 Lee Jun E SSB-DNA polymerase fusion proteins
EP2029782B1 (en) 2006-05-04 2014-11-26 Alere San Diego, Inc. Recombinase polymerase amplification
WO2008108927A2 (en) * 2007-03-06 2008-09-12 Regenerx Biopharmaceuticals, Inc. Methods and compositions for stabilizing polypeptides
CA2946024C (en) 2007-05-03 2020-06-02 Clondiag Gmbh Devices and methods for detecting analytes
US8560130B2 (en) 2007-12-04 2013-10-15 Lester F. Ludwig Software controlled lab-on-a-chip emulation
CN102026725B (zh) 2008-03-14 2014-10-29 科隆迪亚戈有限公司 一种用于检测样品中分析物的装置及其方法
WO2010141940A1 (en) 2009-06-05 2010-12-09 Alere San Diego, Inc. Recombinase polymerase amplification reagents and kits
KR20120093882A (ko) 2009-09-16 2012-08-23 마쎄이 유니버시티 융합 폴리펩티드 및 이들의 용도
JP6490576B2 (ja) 2012-04-12 2019-03-27 ニユー・イングランド・バイオレイブス・インコーポレイテツド 重合反応のための合成核酸
US10533167B2 (en) 2016-06-09 2020-01-14 The Trustees Of Princeton University Optogenetic tool for rapid and reversible clustering of proteins
WO2018100408A1 (en) * 2016-11-30 2018-06-07 Sasinapas Co.,Ltd. Modified peptides
EP3743435B1 (en) 2018-01-24 2023-08-09 The Trustees Of Princeton University System and method for inducing clusters of gene regulatory proteins targeted to specific genomic loci
GB201916379D0 (en) 2019-11-11 2019-12-25 Biocrucible Ltd Biochemical reaction methods and reagents

Also Published As

Publication number Publication date
GB201916379D0 (en) 2019-12-25
AU2020382121A1 (en) 2022-06-16
AU2020382121B2 (en) 2026-06-18
IL292885A (en) 2022-07-01
JP7840266B2 (ja) 2026-04-03
CA3157435A1 (en) 2021-05-20
MX2022005677A (es) 2022-09-07
CN114945682A (zh) 2022-08-26
JP2023501002A (ja) 2023-01-17
AU2020382121A8 (en) 2022-07-28
JP2026041819A (ja) 2026-03-10
US20220112547A1 (en) 2022-04-14
EP4058599A1 (en) 2022-09-21
BR112022009072A2 (pt) 2022-07-26
US11807899B2 (en) 2023-11-07
KR20220113948A (ko) 2022-08-17
WO2021094746A1 (en) 2021-05-20
US20220145378A1 (en) 2022-05-12
US12618102B2 (en) 2026-05-05

Similar Documents

Publication Publication Date Title
MX2022005677A (es) Procedimientos y reactivos de reaccion bioquimica que comprenden regiones intrinsecamente desordenadas.
CY1124717T1 (el) Μεθοδοι, kit και συσκευη για επεκταση πληθυσμου κυτταρων
EP4265723A3 (en) Reagents and methods for molecular barcoding of nucleic acids of single cells
EP4345172A3 (en) Sample indexing for single cells
BRPI0812878C1 (pt) anticorpo isolado ou parte funcional do mesmo, vetor, método para produzir um anticorpo ou uma parte funcional do mesmo, para produzir uma célula produtora de anticorpo e para produzir um anticorpo capaz de se ligar especificamente a rsv, composição, e, uso de um anticorpo ou parte funcional do mesmo ou de uma composição ou de vetor
EP4219720A3 (en) Engineered cascade components and cascade complexes
BR112022002695A2 (pt) Nucleases guiadas por rna, fragmentos ativos e variantes das mesmas e métodos de uso
EP4667583A3 (en) Multiple tagging of long dna fragments
BR112021017931A2 (pt) Método, e, sistema
WO2019135816A3 (en) Novel nucleic acid modifiers
EP4372084A3 (en) Compositions and methods for targeted nucleic acid sequence enrichment and high efficiency library generation
WO2016145416A3 (en) Proteomic analysis with nucleic acid identifiers
WO2016126871A3 (en) Sequencing of nucleic acids via barcoding in discrete entities
WO2015160895A3 (en) Modified transposases for improved insertion sequence bias and increased dna input tolerance
BR112014027239A2 (pt) peptídeo, método de identificação de peptídeos, método para o tratamento de câncer, nucleotídeo, vetor, uso de um peptídeo e invenção
SA516371797B1 (ar) تركيبة وطريقة لثبات الأحماض النووية في عينات بيولوجية
WO2019055926A3 (en) Method for using aqueous two-phase system for the isolation, purification and/or concentration of short nucleic acid fragments
EP4105644A3 (en) Systems and devices for sequence by synthesis analysis
SG10201903822XA (en) Method for the enrichment of circulating tumor dna
SG11202011050TA (en) Methods and reagents for resolving nucleic acid mixtures and mixed cell populations and associated applications
BR112019005810A2 (pt) método para sequenciamento de microbioma melhorado para caracterizar uma afecção relacionada a micro-organismo para um usuário associado a uma amostra biológica, e método para sequenciamento de microbioma melhorado
MX2015012319A (es) Sistemas de instrumento analitico.
EP4553171A3 (en) Nucleic acid sequencing method
FI20175460A7 (fi) Ionisaatiolaite
WO2024081738A3 (en) Compositions, methods, and systems for dna modification